NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQ: ASPI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Five9, Inc. (“Five9” or the “Company”) (NASDAQ: FIVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Customers Bancorp, Inc. (“Match” or the “Company”) (NYSE: CUBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSE: ZETA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ: CELH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Micron Technology, Inc. (“Micron” or the “Company”) (NASDAQ:MU) and certain officers. The class action, filed in the United States District Court for the Southern District of…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) and certain officers. The class action, filed in the United States District Court for the Middle…

NEW YORK, Jan. 14, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQ: AEHR) and certain officers. The class action, filed in the United States District Court for the Northern District…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.